Nicola Brunetti-Pierri

Professore Ordinario

Università degli Studi di Napoli Federico II

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Nicola Brunetti-Pierri is a Professore Ordinario at Università degli Studi di Napoli Federico II in Italy. His research focuses on genetic disorders, gene therapy, and precision medicine, as demonstrated by his recent publications on neurodevelopmental disorders, DNA methylation syndromes, and adeno-associated virus vector-mediated therapies. He is dedicated to advancing the understanding and treatment of various metabolic and genetic diseases.

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

Vincenzo Nigro

Full professor of medical genetics

Università degli Studi della Campania Luigi Vanvitelli

ITALY

View details

Pavel Strnad

University Hospital RWTH Aachen

GERMANY

View details

DEBORAH FRENCH

Professor

University of Pennsylvania

UNITED STATES

View details

Ilse Meerschaut

University Hospitals Leuven

BELGIUM

View details

B. Callewaert

BELGIUM

View details

Antonio Rinaldi

Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche

ITALY

View details

Carolin Victoria Schneider

University Hospital RWTH Aachen

GERMANY

View details

Lars Schlotawa

GERMANY

View details

Francesco Napolitano

Assistant Professor

University of Sannio

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nicola Brunetti-Pierri

Research Interests

Explore related searches

Contact this professor

About

Articles (21)

Computational identification of small molecules for increased gene expression by synthetic circuits in mammalian cells

A Further Case Supporting PDCD6IP as the Gene Responsible for a Neurodevelopmental Disorder With Microcephaly

DNA methylation episignature for Smith-Magenis and Potocki-Lupski syndromes: a mirror perspective

Expansion of the Phenotype of You‐Hoover‐Fong Syndrome and Possible Increased Risk of Cancer

Current and Emerging Issues in Adeno-Associated Virus Vector-Mediated Liver-Directed Gene Therapy

SNRK tames mTOR against metabolic dysfunction-associated steatotic liver disease

Biomarkers for gene therapy clinical trials of lysosomal storage disorders

Precision medicine in action for Pompe disease

Liver gene transfer for metabolite detoxification in inherited metabolic diseases

Liver‐directed gene therapy for inherited metabolic diseases

Gene therapies for mucopolysaccharidoses

Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency

Vision on gyrate atrophy: why treat the liver?

Are SHROOM4 loss‐of‐function variants pathogenic?

Expanded cardiovascular phenotype of Myhre syndrome includes tetralogy of Fallot suggesting a role for SMAD4 in human neural crest defects

A retrograde approach for liver gene transfer

Liver CHOP‐and‐change stress response

Liver gene therapy: The magic bullet for the sick lung

Expanding the phenotype of HNRNPU‐related neurodevelopmental disorder with emphasis on seizure phenotype and review of literature

Mild neurological phenotype in a family carrying a novel N-terminal null GRIN2A variant

Alpha-1 antitrypsin deficiency: A re-surfacing adult liver disorder

Collaborators (9)

Vincenzo Nigro

Pavel Strnad

DEBORAH FRENCH

Ilse Meerschaut

B. Callewaert

Antonio Rinaldi

Carolin Victoria Schneider

Lars Schlotawa

Francesco Napolitano

Make your next move.